UC Law professor discusses upcoming US Supreme Court decision
Ryan Thoreson, an assistant professor at the University of Cincinnati College of Law, spoke with Newsweek about arguments before the U.S. Supreme Court for the case Chiles v. Salazar.
That case focuses on the use of conversion therapy, the practice of trying to change a person’s sexual orientation or gender identity through counseling. Kaley Chiles, a counselor in Colorado, is challenging the state’s law prohibiting the use of conversion therapy on minors before the high court.
In a petition to the Supreme Court, her attorneys wrote that she is a "licensed counselor who helps people by talking with them." Conversion therapy for minors is banned in more than 20 states, reports Newsweek.
Thoreson told Newsweek he believes Colorado has strong arguments in favor of its ban, but that he is "skeptical this Court will uphold the state's conversion therapy ban in light of its recent First Amendment rulings."
States currently regulate the conduct of medical professionals and can prohibit practices that fall below a certain standard of care, Thoreson says.
"And they can do so even when that conduct involves some amount of speech,” Thoreson told Newsweek.
Read the full Newsweek article online.
Learn more about UC Law’s Ryan Thoreson online.
Featured top image of the U.S. Supreme Court. Photo/Istock.
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
Telescope captures information about lonely Jupiter-like gas giant
May 13, 2026
Science outlets highlight a University of Cincinnati student's collaborative discoveries about an exoplanet 901 light years away.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.